Androgen R/NR3C4 [p Ser213, p Ser210] Antibody (156C135.2) - BSA Free NB100-56603 from Novus Biologicals, a Bio-Techne Brand

Product Specs
ItemAndrogen R/NR3C4 [p Ser213, p Ser210] Antibody (156C135.2) - BSA Free
CompanyNovus Biologicals, a Bio-Techne Brand
Price Pricing Info Supplier Page View Company Product Page
Catalog NumberNB100-56603
NCBI Gene AliasesTFM, KD, AR8, HUMARA, NR3C4, AIS, SBMA, HYSP1, SMAX1, DHTR
ImmunogenThis antibody was developed against a synthetic peptide corresponding to amino acids 207-221 (GRAREAS*GAPTSSKD) of human androgen receptor, containing the serine 213 phosphorylation site: GenBank Accession No. A39248. Note: S* refers to phosphorylated serine in the peptide sequence
Conjugate/TagUnconjugated
Quantity0.1 mg (also 0.025 mg)
HostMouse
Clone156C135.2
ClonalityMonoclonal
ReactivityHuman, Mouse, Rat, Canine, Primate
ApplicationsWestern Blot, Immunohistochemistry, Immunohistochemistry-Paraffin
TargetAndrogen R/NR3C4
IsotypeIgG1 Kappa
FormatPBS
Concentration1.0 mg/ml
NCBI Full Gene Nameandrogen receptor
Modificationsp Ser213, p Ser210
Brand/TrademarkNovus Biologicals, a Bio-Techne Brand
PurityProtein G purified
Research AreaBreast Cancer, Cancer, Phospho Specific
Antibody TypePrimary Antibodies
StorageStore at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles

Available conjugates: Unconjugated

Specificity: In IGF-1 stimulated LNCaP cells (passage number 38), a ~110 kDa band was observed

United States: 10771 E Easter Ave

Centennial, Colorado 80112

United States

Phone:
303-730-1950
888-506-6887

Email: novus@novusbio.com

(1) The protein arginine methyltransferases (PRMTs) PRMT1 and CARM1 as candidate epigenetic drivers in prostate cancer progressionMedicineSeptember 10, 2021Grypari IM, Logotheti S, Zolota V, Troncoso P, Efstathiou E, Bravou V, Melachrinou M, Logothetis C, Tzelepi V.

(2) Androgen receptor phosphorylation at serine 81 and serine 213 in castrate-resistant prostate cancerProstate cancer and prostatic diseasesDecember 1, 2020McAllister MJ, McCall P, Dickson A, Underwood MA, Andersen D, Holmes E, Markert E, Leung HY, Edwards J.

(6) Androgen regulated HN1 leads proteosomal degradation of androgen receptor (AR) and negatively influences AR mediated transactivation in prostate cellsMolecular and cellular endocrinologyMarch 5, 2012Varisli L, Gonen-Korkmaz C, Syed HM, Bogurcu N, Debelec-Butuner B, Erbaykent-Tepedelen B, Korkmaz KS.

(7) Differential transformation capacity of Src family kinases during the initiation of prostate cancerProceedings of the National Academy of Sciences of the United States of AmericaApril 19, 2011Cai H, Smith DA, Memarzadeh S, Lowell CA, Cooper JA, Witte ON.

(9) Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicityHuman molecular geneticsJuly 1, 2007Palazzolo I, Burnett BG, Young JE, Brenne PL, La Spada AR, Fischbeck KH, Howell BW, Pennuto M.

(13) Observer variation in immunohistochemical analysis of protein expression, time for a change?HistopathologyJune 1, 2006Kirkegaard T, Edwards J, Tovey S, McGlynn LM, Krishna SN, Mukherjee R, Tam L, Munro AF, Dunne B, Bartlett JM.

Androgen R/NR3C4 [p Ser213, p Ser210] Antibody (156C135.2) - BSA Free